Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Robotic-assisted Trans-peritoneal Pelvic Lymphadenectomy For Metastatic Melanoma: Early Outcomes Compared To Open Pelvic Lymphadenectomy</title><author><name sortKey="Dossett, Lesly A" sort="Dossett, Lesly A" uniqKey="Dossett L" first="Lesly A." last="Dossett">Lesly A. Dossett</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Castner, Nicholas B" sort="Castner, Nicholas B" uniqKey="Castner N" first="Nicholas B." last="Castner">Nicholas B. Castner</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Pow Sang, Julio M" sort="Pow Sang, Julio M" uniqKey="Pow Sang J" first="Julio M." last="Pow-Sang">Julio M. Pow-Sang</name><affiliation><nlm:aff>NONE</nlm:aff></affiliation></author><author><name sortKey="Abbott, Andrea M" sort="Abbott, Andrea M" uniqKey="Abbott A" first="Andrea M." last="Abbott">Andrea M. Abbott</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Sondak, Vernon K" sort="Sondak, Vernon K" uniqKey="Sondak V" first="Vernon K." last="Sondak">Vernon K. Sondak</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Sarnaik, Amod A" sort="Sarnaik, Amod A" uniqKey="Sarnaik A" first="Amod A." last="Sarnaik">Amod A. Sarnaik</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Zager, Jonathan S" sort="Zager, Jonathan S" uniqKey="Zager J" first="Jonathan S." last="Zager">Jonathan S. Zager</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26875071</idno><idno type="pmc">4871144</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871144</idno><idno type="RBID">PMC:4871144</idno><idno type="doi">10.1016/j.jamcollsurg.2015.12.033</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">003995</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003995</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Robotic-assisted Trans-peritoneal Pelvic Lymphadenectomy For Metastatic Melanoma: Early Outcomes Compared To Open Pelvic Lymphadenectomy</title><author><name sortKey="Dossett, Lesly A" sort="Dossett, Lesly A" uniqKey="Dossett L" first="Lesly A." last="Dossett">Lesly A. Dossett</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Castner, Nicholas B" sort="Castner, Nicholas B" uniqKey="Castner N" first="Nicholas B." last="Castner">Nicholas B. Castner</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Pow Sang, Julio M" sort="Pow Sang, Julio M" uniqKey="Pow Sang J" first="Julio M." last="Pow-Sang">Julio M. Pow-Sang</name><affiliation><nlm:aff>NONE</nlm:aff></affiliation></author><author><name sortKey="Abbott, Andrea M" sort="Abbott, Andrea M" uniqKey="Abbott A" first="Andrea M." last="Abbott">Andrea M. Abbott</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Sondak, Vernon K" sort="Sondak, Vernon K" uniqKey="Sondak V" first="Vernon K." last="Sondak">Vernon K. Sondak</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Sarnaik, Amod A" sort="Sarnaik, Amod A" uniqKey="Sarnaik A" first="Amod A." last="Sarnaik">Amod A. Sarnaik</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author><author><name sortKey="Zager, Jonathan S" sort="Zager, Jonathan S" uniqKey="Zager J" first="Jonathan S." last="Zager">Jonathan S. Zager</name><affiliation><nlm:aff id="A1">Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of the American College of Surgeons</title><idno type="ISSN">1072-7515</idno><idno type="eISSN">1879-1190</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P1">In the absence of iliac or obturator nodal involvement, the role of pelvic lymphadenectomy (PLND) for melanoma is controversial, but for select patients long-term survival may be achieved with the combination of superficial inguinal (inguinofemoral) and pelvic lymphadenectomy. Open PLND (oPLND) is often limited in visual exposure and may be associated with significant postoperative pain. Robotic PLND (rPLND) is a minimally invasive technique that provides excellent visualization of the iliac and obturator nodes. Outcomes comparing the open and robotic techniques for have not been previously reported for patients with melanoma.</p></sec><sec id="S2"><title>Study Design</title><p id="P2">We reviewed our experience with rPLND for melanoma and compared clinical and pathologic results to oPLND. We evaluated operative times, nodal yield and short-term oncologic outcomes.</p></sec><sec id="S3"><title>Results</title><p id="P3">13 rPLND (2013–2015) (15 attempted, 87% success rate) and 25 oPLND (2010–2015) consecutive cases were completed. PLND was combined with an open inguinofemoral dissection in 8 of 13 (62%) robotic and 17 of 25 (68%) open cases. Median length of stay (LOS) was shorter in the rPLND group with 1.0 versus 3.5 days for pelvic only cases (p<0.001) and 2.5 versus 4.0 days (p<0.001) for combined ilioinguinal cases. Median operative time (227 versus 230 minutes, p=0.96) and nodal yield (11 versus 10 nodes, p=0.53) were not different between rPLND and oPLND.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">rPLND offers a safe, effective minimally invasive approach to resect the pelvic lymph nodes in patients with melanoma, with no significant difference in nodal yield or operative times, but a shorter LOS compared to oPLND.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9431305</journal-id><journal-id journal-id-type="pubmed-jr-id">8488</journal-id><journal-id journal-id-type="nlm-ta">J Am Coll Surg</journal-id><journal-id journal-id-type="iso-abbrev">J. Am. Coll. Surg.</journal-id><journal-title-group><journal-title>Journal of the American College of Surgeons</journal-title></journal-title-group><issn pub-type="ppub">1072-7515</issn><issn pub-type="epub">1879-1190</issn></journal-meta><article-meta><article-id pub-id-type="pmid">26875071</article-id><article-id pub-id-type="pmc">4871144</article-id><article-id pub-id-type="doi">10.1016/j.jamcollsurg.2015.12.033</article-id><article-id pub-id-type="manuscript">NIHMS784798</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Robotic-assisted Trans-peritoneal Pelvic Lymphadenectomy For Metastatic Melanoma: Early Outcomes Compared To Open Pelvic Lymphadenectomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dossett</surname><given-names>Lesly A.</given-names></name><degrees>MD, MPH, FACS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Castner</surname><given-names>Nicholas B.</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pow-Sang</surname><given-names>Julio M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Abbott</surname><given-names>Andrea M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sondak</surname><given-names>Vernon K.</given-names></name><degrees>MD, FACS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sarnaik</surname><given-names>Amod A.</given-names></name><degrees>MD, FACS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zager</surname><given-names>Jonathan S.</given-names></name><degrees>MD, FACS</degrees><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</aff><aff id="A2"><label>2*</label>Department of Genito-Urinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL</aff><author-notes><corresp id="cor1">Corresponding Author. Jonathan S. Zager, MD FACS, Director of Regional Therapies, Department of Cutaneous Oncology, Moffitt Cancer Center, Professor of Surgery, University of South Florida Morsani School of Medicine, 12902 Magnolia Drive, Tampa, FL 33612, Tel: 813-745-1085, Fax: 813-745-5725, <email>jonathan.zager@moffitt.org</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>13</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>14</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>4</month><year>2017</year></pub-date><volume>222</volume><issue>4</issue><fpage>702</fpage><lpage>709</lpage><pmc-comment>elocation-id from pubmed: 10.1016/j.jamcollsurg.2015.12.033</pmc-comment>
<abstract><sec id="S1"><title>Background</title><p id="P1">In the absence of iliac or obturator nodal involvement, the role of pelvic lymphadenectomy (PLND) for melanoma is controversial, but for select patients long-term survival may be achieved with the combination of superficial inguinal (inguinofemoral) and pelvic lymphadenectomy. Open PLND (oPLND) is often limited in visual exposure and may be associated with significant postoperative pain. Robotic PLND (rPLND) is a minimally invasive technique that provides excellent visualization of the iliac and obturator nodes. Outcomes comparing the open and robotic techniques for have not been previously reported for patients with melanoma.</p></sec><sec id="S2"><title>Study Design</title><p id="P2">We reviewed our experience with rPLND for melanoma and compared clinical and pathologic results to oPLND. We evaluated operative times, nodal yield and short-term oncologic outcomes.</p></sec><sec id="S3"><title>Results</title><p id="P3">13 rPLND (2013–2015) (15 attempted, 87% success rate) and 25 oPLND (2010–2015) consecutive cases were completed. PLND was combined with an open inguinofemoral dissection in 8 of 13 (62%) robotic and 17 of 25 (68%) open cases. Median length of stay (LOS) was shorter in the rPLND group with 1.0 versus 3.5 days for pelvic only cases (p<0.001) and 2.5 versus 4.0 days (p<0.001) for combined ilioinguinal cases. Median operative time (227 versus 230 minutes, p=0.96) and nodal yield (11 versus 10 nodes, p=0.53) were not different between rPLND and oPLND.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">rPLND offers a safe, effective minimally invasive approach to resect the pelvic lymph nodes in patients with melanoma, with no significant difference in nodal yield or operative times, but a shorter LOS compared to oPLND.</p></sec></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0039959 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0039959 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |